Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
Adopted EU legal act under scrutiny for incorporation into the EEA Agreement by Iceland, Liechtenstein and Norway
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XXX Medical Devices
Legal Documents
Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95
Verordnung (EU) 2024/568 des Europäischen Parlaments und des Rates vom 7. Februar 2024 über die an die Europäische Arzneimittel-Agentur zu entrichtenden Gebühren und Entgelte, zur Änderung der Verordnungen (EU) 2017/745 und (EU) 2022/123 des Europäischen Parlaments und des Rates sowie zur Aufhebung der Verordnung (EU) Nr. 658/2014 des Europäischen Parlaments und des Rates und der Verordnung (EG) Nr. 297/95 des Rates
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.